• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美沙酮维持治疗药物对美国住院治疗完成和保留的影响。

The effect of medications for opioid use disorder (MOUD) on residential treatment completion and retention in the US.

机构信息

Department of Geography and Urban Studies, Temple University, Philadelphia, PA 19122, United States.

出版信息

Drug Alcohol Depend. 2020 Jul 1;212:108067. doi: 10.1016/j.drugalcdep.2020.108067. Epub 2020 May 15.

DOI:10.1016/j.drugalcdep.2020.108067
PMID:32445926
Abstract

BACKGROUND

This study examines whether MOUD increases treatment completion and retention in both short-term (ST) and long-term (LT) residential programs using a national dataset.

METHODS

Data were extracted from the 2015-2017 TEDS-D (Treatment Episode Dataset-Discharge) datasets for opioid using adults in ST (n = 87,296) and LT (n = 66,623) residential treatment. Primary outcome variables were treatment completion and retention (ST: length of stay >10 days; LT: >90 days). Logistic regression estimated the effects of MOUD on the probability of treatment completion and retention separately for ST and LT residential treatment, controlling for individual background characteristics.

RESULTS

Only 18% of clients in residential treatment programs had MOUD in their treatment plans. For ST residential treatment, MOUD was associated with a 40% increased likelihood of treatment completion (OR = 1.404) and 34% increased retention (OR = 1.337). For LT residential treatment, MOUD was associated with a 26% reduced likelihood of treatment completion (OR = 0.743) and no significant increase in retention. Post hoc analysis suggests insurance coverage may be influencing outcomes.

CONCLUSIONS

Despite MOUD being a standard of care for OUD, MOUD is particularly under-utilized in residential treatment. Further research should focus on how best to integrate MOUD within short-term residential treatment and to explore the potential viability of MOUD in long-term residential programs. Given the risk of overdose following residential treatment, for at least short-term residential programs, this setting may be advantageous for integrating psychosocial treatments with early MOUD engagement in a structured therapeutic environment as part of a long-term continuum of care recovery program.

摘要

背景

本研究使用全国性数据集,考察美沙酮维持治疗(MOUD)是否会提高短期(ST)和长期(LT)住院治疗项目中的治疗完成率和保留率。

方法

从 2015-2017 年 TEDS-D(治疗期数据集-出院)阿片类药物使用成人 ST(n=87296)和 LT(n=66623)住院治疗数据集中提取数据。主要结局变量为治疗完成率和保留率(ST:住院时间>10 天;LT:>90 天)。逻辑回归分别估计了 MOUD 对 ST 和 LT 住院治疗的治疗完成率和保留率的影响,同时控制了个体背景特征。

结果

只有 18%的住院治疗计划中的患者有 MOUD 治疗计划。对于 ST 住院治疗,MOUD 与治疗完成率增加 40%(OR=1.404)和保留率增加 34%(OR=1.337)相关。对于 LT 住院治疗,MOUD 与治疗完成率降低 26%(OR=0.743)和保留率无显著增加相关。事后分析表明,保险覆盖可能会影响结果。

结论

尽管 MOUD 是 OUD 的标准治疗方法,但 MOUD 在住院治疗中的应用尤其不足。进一步的研究应集中在如何最好地将 MOUD 整合到短期住院治疗中,并探索 MOUD 在长期住院治疗项目中的潜在可行性。鉴于住院治疗后过量用药的风险,对于至少短期住院治疗项目而言,这种环境可能有利于在结构化治疗环境中整合心理社会治疗和早期 MOUD 参与,作为长期康复计划连续性护理的一部分。

相似文献

1
The effect of medications for opioid use disorder (MOUD) on residential treatment completion and retention in the US.美沙酮维持治疗药物对美国住院治疗完成和保留的影响。
Drug Alcohol Depend. 2020 Jul 1;212:108067. doi: 10.1016/j.drugalcdep.2020.108067. Epub 2020 May 15.
2
Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US.美国在使用治疗阿片类药物使用障碍(MOUD)药物方面的种族/民族差异及其对住院药物治疗结果的影响。
Drug Alcohol Depend. 2021 Sep 1;226:108849. doi: 10.1016/j.drugalcdep.2021.108849. Epub 2021 Jun 24.
3
Treatment outcomes associated with medications for opioid use disorder (MOUD) among criminal justice-referred admissions to residential treatment in the U.S., 2015-2018.2015-2018 年美国刑事司法转介住院治疗的阿片类药物使用障碍(MOUD)患者使用药物治疗的结果。
Drug Alcohol Depend. 2022 Jul 1;236:109498. doi: 10.1016/j.drugalcdep.2022.109498. Epub 2022 May 14.
4
Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.俄勒冈州医疗补助计划中患有阿片类药物使用障碍患者的治疗环境与结局之间的关联:一项回顾性队列研究。
Addict Sci Clin Pract. 2022 Aug 19;17(1):45. doi: 10.1186/s13722-022-00318-1.
5
Outpatient follow-up and use of medications for opioid use disorder after residential treatment among Medicaid enrollees in 10 states.10 个州医疗补助计划参保者经住院治疗后门诊随访和阿片类药物使用障碍药物使用情况。
Drug Alcohol Depend. 2022 Dec 1;241:109670. doi: 10.1016/j.drugalcdep.2022.109670. Epub 2022 Oct 21.
6
Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis.住院医学管理的阿片类药物戒断后死亡率与药物治疗和住院治疗的关系:队列分析。
Addiction. 2020 Aug;115(8):1496-1508. doi: 10.1111/add.14964. Epub 2020 Feb 25.
7
The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder.精神共病对接受阿片类药物使用障碍药物治疗者停药的影响。
Drug Alcohol Depend. 2020 Nov 1;216:108244. doi: 10.1016/j.drugalcdep.2020.108244. Epub 2020 Aug 22.
8
Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the U.S.美国接受治疗的孕妇药物滥用障碍用药的相关因素
Int J Drug Policy. 2024 Apr;126:104342. doi: 10.1016/j.drugpo.2024.104342. Epub 2024 Mar 13.
9
Medication for opioid use disorder treatment and specialty outpatient substance use treatment outcomes: Differences in retention and completion among opioid-related discharges in 2016.用于阿片类物质使用障碍治疗的药物及专科门诊物质使用治疗结果:2016年阿片类物质相关出院患者在留院治疗和完成治疗方面的差异。
J Subst Abuse Treat. 2020 Jul;114:108028. doi: 10.1016/j.jsat.2020.108028. Epub 2020 May 11.
10
Predictors of availability of long-acting medication for opioid use disorder.阿片类药物使用障碍长效药物供应的预测因素。
Drug Alcohol Depend. 2019 Nov 1;204:107586. doi: 10.1016/j.drugalcdep.2019.107586. Epub 2019 Sep 25.

引用本文的文献

1
Exploring the Determinants of Treatment Completion Among Youth Who Received Medication-Assisted Treatment in the United States.探究美国接受药物辅助治疗的青少年完成治疗的决定因素。
Healthcare (Basel). 2025 Apr 2;13(7):798. doi: 10.3390/healthcare13070798.
2
Buprenorphine use among non-hospital residential programs.美沙酮在非住院住所项目中的使用。
Drug Alcohol Depend. 2024 Nov 1;264:112456. doi: 10.1016/j.drugalcdep.2024.112456. Epub 2024 Sep 26.
3
Challenges and recommendations for overdose prevention and harm reduction in an era of fentanyl and xylazine: Perspectives of women with opioid use disorder and professionals.
芬太尼和唑吡坦时代下阿片类药物使用障碍女性和专业人士对过量预防和减少伤害的挑战和建议。
Psychol Addict Behav. 2024 Dec;38(8):860-870. doi: 10.1037/adb0001021. Epub 2024 Aug 22.
4
Barriers to retention in inpatient and residential drug treatment among persons who use opioids and/or injection drugs living in the rural U.S.美国农村地区使用阿片类药物和/或注射药物的住院和住院戒毒治疗中保留率的障碍
J Subst Use Addict Treat. 2024 Oct;165:209453. doi: 10.1016/j.josat.2024.209453. Epub 2024 Jul 20.
5
How Does Telehealth Expansion Change Access to Healthcare for Patients With Different Types of Substance Use Disorders?远程医疗的扩展如何改变不同类型物质使用障碍患者获得医疗保健的机会?
Subst Use Addctn J. 2024 Jul;45(3):473-485. doi: 10.1177/29767342241236028. Epub 2024 Mar 17.
6
Use of residential opioid use disorder treatment among Medicaid enrollees in nine states.九个州医疗补助计划参保者中使用住宅阿片类药物使用障碍治疗的情况。
J Subst Use Addict Treat. 2023 Jun;149:209034. doi: 10.1016/j.josat.2023.209034. Epub 2023 Apr 12.
7
The association between medication for opioid use disorder and employment outcomes in the U.S.: The relevance of race and ethnicity.美国阿片类药物使用障碍药物治疗与就业结果之间的关联:种族和族裔的相关性。
Drug Alcohol Depend Rep. 2022 Jul 27;4:100081. doi: 10.1016/j.dadr.2022.100081. eCollection 2022 Sep.
8
Retention in treatment and therapeutic adherence: How are these associated with therapeutic success? An analysis using real-world data.治疗中的保留和治疗依从性:这些与治疗成功有何关联?使用真实世界数据进行的分析。
Int J Methods Psychiatr Res. 2022 Dec;31(4):e1929. doi: 10.1002/mpr.1929. Epub 2022 Jun 28.
9
Disparities in opioid treatment access and retention among women based on pregnancy status from 2006 to 2017.2006年至2017年期间,基于妊娠状态的女性在阿片类药物治疗可及性和留存率方面的差异。
Drug Alcohol Depend Rep. 2022 Mar;2. doi: 10.1016/j.dadr.2022.100030. Epub 2022 Feb 2.
10
Association of facility characteristics and substance use disorder outcomes at discharge from residential treatment.从住院治疗出院时设施特点与物质使用障碍结果的关联。
J Subst Abuse Treat. 2022 May;136:108664. doi: 10.1016/j.jsat.2021.108664. Epub 2021 Nov 15.